Missionpharma, officially known as Missionpharma A/S, is a leading provider of healthcare solutions headquartered in Denmark (DK). Established in 2000, the company has made significant strides in the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical devices across various regions, including Africa and Asia. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including generic pharmaceuticals, surgical instruments, and diagnostic tools. Their unique approach combines quality assurance with competitive pricing, ensuring that healthcare providers receive reliable products tailored to their needs. Recognised for their dedication to social responsibility, Missionpharma has positioned itself as a trusted partner in global health initiatives, contributing to improved health outcomes in underserved communities.
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Missionpharma's score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of 2024, Missionpharma, headquartered in Denmark (DK), has not disclosed specific carbon emissions data, including Scope 1, 2, or 3 emissions. The company has not set any reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. In previous years, Missionpharma has reported emissions data, but the details for 2023, 2022, and earlier years remain unspecified. The absence of disclosed emissions figures indicates a need for enhanced transparency in their climate commitments. Missionpharma's approach to sustainability and climate action appears to be in its early stages, with no significant reduction targets or achievements reported. The company may benefit from establishing clear emissions reduction goals and participating in recognised climate initiatives to align with industry standards and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Missionpharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.